Defence Announces Successful Presentation at the World ADC Conference in San Diego and Plans to Expand Evaluation of Accum in Commercial and Pipeline ADCs #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #CSEStocks #OTC #OTCMarkets #OTCStocks #SmallCaps #Investing
Montreal, Quebec--(Newsfile Corp. - November 6, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company pioneering next-generation antibody-drug conjugate ("ADC"), is pleased to announce the successful presentation of new data on its proprietary Accum® platform at the 16th World ADC Conference in San Diego, USA (November 4-5, 2025).The presentation generated exceptional interest from both the scientific and industry...
http://dlvr.it/TP618t
http://dlvr.it/TP618t
Comments
Post a Comment